← All organizations
Highest phase reached
Phase 3
First clinical trial
May 12, 2018Last known activity
Feb 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT06789744Sponsor investigatorN/AFeb 1, 2025
- NCT06798662Sponsor investigatorN/AFeb 1, 2025
- NCT06772558Sponsor investigatorN/AFeb 1, 2025
- NCT06789744Lead sponsorN/AFeb 1, 2025
- NCT06798662Lead sponsorN/AFeb 1, 2025
- NCT06772558Lead sponsorN/AFeb 1, 2025
- NCT06608810Lead sponsorN/AJul 30, 2023
- NCT05159947CollaboratorPhase 3Dec 31, 2021
- NCT04676659CollaboratorPhase 2May 12, 2018
Details
- Last known activity
- Feb 1, 2025